Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 CAD | -.--% |
|
-.--% | -.--% |
Apr. 19 | Orion Nutraceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 13 | Joel Dumaresq Resigns as Director of Orion Nutraceuticals Inc | CI |
Business Summary
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Guy Bourgeois
CEO | Chief Executive Officer | - | 23-06-06 |
Amanda Boudreau
BRD | Director/Board Member | - | 23-06-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,307,965 | 28,907,965 ( 98.64 %) | 0 | 98.64 % |
Company contact information
Orion Nutraceuticals, Inc.
789 West Pender Street Suite 810
V6C 1H2, Vancouver
+
![address Orion Nutraceuticals Inc.(ORI)](https://cdn.zonebourse.com/static/address/55018349.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 8.68M | |
+12.92% | 4.95B | |
-32.29% | 3.6B | |
-4.28% | 3.03B | |
-24.21% | 2.66B | |
-8.82% | 2.34B | |
+39.33% | 1.85B | |
+40.81% | 1.45B | |
-14.27% | 1.41B | |
+41.90% | 1.38B |
- Stock Market
- Equities
- ORI Stock
- Company Orion Nutraceuticals Inc.